A Study of Guselkumab in Participants With Crohn's Disease and Ulcerative Colitis

Clinical trial NCT07606339 · RECRUITING

Trial details

NCT number: NCT07606339
Sponsor: Janssen-Cilag Pharma GmbH
Status: RECRUITING
Study type: OBSERVATIONAL

Crohn Disease Colitis, Ulcerative

Start date: 2026-06-10
Primary completion: 2029-06-15
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.